WO2010105842A9 - Zubereitung zur äusserlichen anwendung - Google Patents

Zubereitung zur äusserlichen anwendung Download PDF

Info

Publication number
WO2010105842A9
WO2010105842A9 PCT/EP2010/001742 EP2010001742W WO2010105842A9 WO 2010105842 A9 WO2010105842 A9 WO 2010105842A9 EP 2010001742 W EP2010001742 W EP 2010001742W WO 2010105842 A9 WO2010105842 A9 WO 2010105842A9
Authority
WO
WIPO (PCT)
Prior art keywords
water
cosmetic
therapeutic
oil
external application
Prior art date
Application number
PCT/EP2010/001742
Other languages
English (en)
French (fr)
Other versions
WO2010105842A2 (de
WO2010105842A3 (de
Inventor
Dirk Schumann
Original Assignee
Bubbles And Beyond Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bubbles And Beyond Gmbh filed Critical Bubbles And Beyond Gmbh
Priority to US13/257,100 priority Critical patent/US20120064011A1/en
Priority to CN2010800128128A priority patent/CN102387787A/zh
Priority to JP2012500151A priority patent/JP2012520837A/ja
Priority to EP10712702A priority patent/EP2408429A2/de
Priority to KR1020147014460A priority patent/KR20150000463A/ko
Publication of WO2010105842A2 publication Critical patent/WO2010105842A2/de
Publication of WO2010105842A3 publication Critical patent/WO2010105842A3/de
Publication of WO2010105842A9 publication Critical patent/WO2010105842A9/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Die vorliegende Erfindung betrifft Zubereitungen zur äußerlichen Anwendung auf die Haut von Tier und Mensch umfassend a) eine Zusammensetzung in Form eines fluides Nanophasensystems umfassend die Komponenten a1) mindestens eine wasserunlösliche Substanz mit einer Wasserlöslichkeit von weniger als 4 Gramm pro Liter, a2) mindestens eine amphiphile Substanz (NP-MCA), die keine Tensidstruktur aufweist, alleine nicht strukturbildend ist, deren Löslichkeit in Wasser bzw. Öl zwischen 4 g und 1000 g pro Liter beträgt und die sich nicht bevorzugt an der Öl-Wasser-Grenzfläche anreichert, a3) mindestens ein anionisches, kationisches, amphoteres und/oder nichtionisches Tensid, a4) mindestens ein polares protisches Lösungsmittel, insbesondere mit Hydroxyfunktionalität, a5) gegebenenfalls ein oder mehrere Hilfsstoffe, wobei sich die Prozentangaben jeweils auf das Gesamtgewicht der Zusammensetzung beziehen, und b) ein therapeutisch, kosmetisch oder diagnostisch wirksames Mittel in einer therapeutisch, kosmetisch oder diagnostisch wirksamen Menge.
PCT/EP2010/001742 2009-03-19 2010-03-19 Zubereitung zur äusserlichen anwendung WO2010105842A2 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US13/257,100 US20120064011A1 (en) 2009-03-19 2010-03-19 Preparation for external application
CN2010800128128A CN102387787A (zh) 2009-03-19 2010-03-19 外用制剂
JP2012500151A JP2012520837A (ja) 2009-03-19 2010-03-19 外用製剤
EP10712702A EP2408429A2 (de) 2009-03-19 2010-03-19 Zubereitung zur äusserlichen anwendung
KR1020147014460A KR20150000463A (ko) 2009-03-19 2010-03-19 외용 제제

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009013469.7 2009-03-19
DE102009013469.7A DE102009013469B4 (de) 2009-03-19 2009-03-19 Zubereitung zur äußerlichen Anwendung

Publications (3)

Publication Number Publication Date
WO2010105842A2 WO2010105842A2 (de) 2010-09-23
WO2010105842A3 WO2010105842A3 (de) 2011-05-26
WO2010105842A9 true WO2010105842A9 (de) 2011-12-01

Family

ID=42536329

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/001742 WO2010105842A2 (de) 2009-03-19 2010-03-19 Zubereitung zur äusserlichen anwendung

Country Status (7)

Country Link
US (1) US20120064011A1 (de)
EP (1) EP2408429A2 (de)
JP (1) JP2012520837A (de)
KR (2) KR20110135973A (de)
CN (1) CN102387787A (de)
DE (1) DE102009013469B4 (de)
WO (1) WO2010105842A2 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG173172A1 (en) 2009-01-28 2011-08-29 Advanced Tech Materials Lithographic tool in situ clean formulations
WO2011028629A1 (en) * 2009-08-26 2011-03-10 Nuvo Research Inc. Pharmaceutical formulations and methods of use
DE102011000322A1 (de) 2011-01-25 2012-07-26 saperatec GmbH Trennmedium, Verfahren und Anlage zum Trennen von Mehrschichtsystemen
US9566306B2 (en) 2012-04-16 2017-02-14 Zemtsov Enterprises, Llc Formulations and methods for treatment of wounds and inflammatory skin conditions
DE102012212281B3 (de) 2012-07-13 2013-10-31 Schülke & Mayr GmbH Mischung von natürlichen bzw. naturidentischen Alkoholen mit verbesserter Wirksamkeit
CN105980540B (zh) * 2013-10-11 2020-04-14 智能液体有限公司 用于剥离光刻胶的智能液体
FR3015889B1 (fr) 2013-12-27 2016-02-05 Oreal Dispositif pour le maquillage par transfert des matieres keratiniques
FR3015887B1 (fr) 2013-12-27 2017-03-24 Oreal Dispositif et procede pour le maquillage par transfert des matieres keratiniques
FR3015872B1 (fr) 2013-12-27 2017-03-24 Oreal Dispositif de maquillage comportant une pluralite d'encres cosmetiques
FR3015927A1 (fr) 2013-12-27 2015-07-03 Oreal Procede de maquillage par transfert et dispositif associe.
FR3015890B1 (fr) 2013-12-27 2016-02-05 Oreal Dispositif pour le maquillage par transfert des matieres keratiniques
FR3015870B1 (fr) * 2013-12-27 2016-02-05 Oreal Dispositif pour le maquillage par transfert des matieres keratiniques.
FR3015888B1 (fr) 2013-12-27 2017-03-31 Oreal Dispositif de maquillage par transfert des matieres keratiniques
CA3066886A1 (en) 2017-06-29 2019-01-03 Societe Des Produits Nestle S.A. Process for making a bouillon tablet or bouillon cube
EP3740156A1 (de) * 2018-01-18 2020-11-25 Zoetis Broomhill IP Limited Interne zitzendichtstoffe und deren verwendung bei der prävention von rindermastitis bei trockenstehenden kühen
BR112020014788A2 (pt) 2018-01-24 2020-12-08 Société des Produits Nestlé S.A. Processo para preparar tablete de caldo
AU2019249723A1 (en) 2018-04-06 2020-08-20 Societe Des Produits Nestle S.A. Process for preparing a bouillon tablet
AU2019249718A1 (en) 2018-04-06 2020-08-20 Societe Des Produits Nestle S.A. Process for preparing a bouillon tablet
WO2019192965A1 (en) 2018-04-06 2019-10-10 Societe Des Produits Nestle S.A. Process for preparing a bouillon tablet
RU2020135825A (ru) 2018-04-06 2022-05-04 Сосьете Де Продюи Нестле С.А. Способ получения бульонной таблетки
PL3790405T3 (pl) 2018-05-09 2024-04-22 Société des Produits Nestlé S.A. Sposób wytwarzania kompozycji spożywczej o ulepszonej sypkości
CA3128434A1 (en) 2019-02-01 2020-08-06 Societe Des Produits Nestle S.A. Bouillon tablet
WO2021037573A1 (en) 2019-08-23 2021-03-04 Société des Produits Nestlé S.A. Process for preparing a bouillon tablet
US20220287327A1 (en) 2019-08-26 2022-09-15 Societe Des Produits Nestle S.A. Meat analogue product comprising hydrated textured plant protein
EP4093215A1 (de) 2020-01-24 2022-11-30 Société des Produits Nestlé S.A. Teilesatz für ein verpacktes nudelprodukt
US20230086169A1 (en) 2020-02-11 2023-03-23 Societe Des Produits Nestle S.A. A process for producing of a bouillon tablet
CN115087364A (zh) 2020-02-11 2022-09-20 雀巢产品有限公司 汤羹片
CN114504551B (zh) * 2020-11-16 2024-01-02 北京厚燊维康科技有限责任公司 可用于光动力治疗或诊断的制剂
EP4329509A1 (de) 2021-04-28 2024-03-06 Société des Produits Nestlé S.A. Zusammensetzung eines dehydrierten fleischanalogprodukts
WO2022229301A1 (en) 2021-04-28 2022-11-03 Société des Produits Nestlé S.A. A composition of a dehydrated meat analogue product
WO2022253643A1 (en) 2021-06-02 2022-12-08 Société des Produits Nestlé S.A. Plant-based meat alternative product with a meat-like color appearance
WO2023217605A1 (en) 2022-05-11 2023-11-16 Société des Produits Nestlé S.A. A process for preparing a meat analogue product
WO2024046744A1 (en) 2022-08-31 2024-03-07 Société des Produits Nestlé S.A. A process for producing a wet savoury product
WO2024188813A1 (en) 2023-03-15 2024-09-19 Société des Produits Nestlé S.A. An extrusion process for preparing a food flavor product
JP7376758B1 (ja) * 2023-07-12 2023-11-09 株式会社Cel-Ena 肌美容方法
CN117224418B (zh) * 2023-11-13 2024-03-19 杭州湃肽生化科技有限公司 一种抗衰老组合物及其产品应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923628A (en) * 1957-11-04 1960-02-02 Harold L Otto Synthetic milk
US4764381A (en) 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US4917896A (en) 1986-08-15 1990-04-17 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agents
DE3729299A1 (de) 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
US5229130A (en) 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US6113921A (en) 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US5853751A (en) 1993-06-23 1998-12-29 Masiz; John J. Molecular transdermal transport system
DE4406753A1 (de) 1994-03-02 1995-09-07 Basf Lacke & Farben Reinigungsmittel, Verfahren zur Herstellung des Reinigungsmittels sowie seine Verwendung
DE69818271T2 (de) * 1997-07-31 2004-06-03 E.I. Du Pont De Nemours And Co., Wilmington Wässerige mikroemulsionen
KR100338327B1 (ko) 2000-05-16 2002-08-07 주식회사 태평양 피부 외용제 내의 활성성분의 피부 흡수를 증진시킬 수있는 조성물
KR100856523B1 (ko) 2000-08-03 2008-09-04 안타레스 파르마 아이피엘 에이쥐 충분한 치료효과를 보장하는 활성 화합물의 경피 및/또는경점막 투여용 신규 조성물
US20030228395A1 (en) * 2002-01-31 2003-12-11 Archer-Daniels Midland Company Isotropic transparent structured fluids
EP2907503A1 (de) * 2003-04-10 2015-08-19 Neurogesx, Inc. Verfahren und Zusammensetzungen zur Verabreichung von TRPV1-Agonisten
WO2005063212A1 (en) * 2003-12-31 2005-07-14 Amorepacific Corporation Cholesteryl hemisuccinate incorporated lipid-based nano-carriers and skin-care compositions for external application containing the same
IL181217A0 (en) * 2007-02-08 2007-07-04 Haim Levy Pharmaceuticalcompositions based on a microemulsion
EP2045320B1 (de) * 2007-09-19 2012-04-25 Bubbles & Beyond Gmbh Reinigungsmittel zur Entfernung von Farbschichten von Oberflächen, Verfahren zur Herstellung des Mittels und Verfahren zur Reinigung

Also Published As

Publication number Publication date
KR20110135973A (ko) 2011-12-20
US20120064011A1 (en) 2012-03-15
WO2010105842A2 (de) 2010-09-23
CN102387787A (zh) 2012-03-21
DE102009013469B4 (de) 2014-04-17
DE102009013469A1 (de) 2010-12-09
EP2408429A2 (de) 2012-01-25
WO2010105842A3 (de) 2011-05-26
KR20150000463A (ko) 2015-01-02
JP2012520837A (ja) 2012-09-10

Similar Documents

Publication Publication Date Title
WO2010105842A9 (de) Zubereitung zur äusserlichen anwendung
WO2019030458A3 (fr) Emulsion moussante a haute teneur en huile et ses utilisations, notamment pour l'hygiene corporelle
CN103222931B (zh) 含有薄荷呋喃和薄荷醇的组合物
WO2011065771A3 (en) Cosmetic composition stabilized higher oily part
JP2010527332A (ja) 界面活性剤不含泡沫処方物
CN105188660A (zh) 化妆品组合物
WO2007117352A3 (en) Topical therapeutic delivery system
PH12015501046B1 (en) Bpo wash emulsion composition
WO2013098066A3 (de) Wässrige haar- und hautreinigungszusammensetzungen, enthaltend biotenside
WO2007112996A3 (en) Use of compounds and combinations of compounds for improving the physical appearance
NZ603686A (en) Topical formulation for a jak inhibitor
SI2437762T1 (en) Artificial tears and therapeutic use
WO2012103038A3 (en) Nanoparticle compositions, formulations thereof, and uses therefor
WO2013130948A3 (en) Sunscreen composition comprising uv composite
CN101198375A (zh) 作为减轻发痒用化妆品和药用组合物的包含邻氨基苯甲酸酰胺和清凉剂的混合物
EP2996668A2 (de) Kosmetische zusammensetzung mit einen sebum-steuerungsmittel, einem hautschuppenablösungsmittel und/oder einem kollagenverstärkenden mittel sowie mit porösen vernetzten polymethylmethacrylat-perlenpartikeln
AU2016222343A1 (en) Compositions and methods for treating blackheads
WO2010091827A3 (de) Kosmetische zubereitung zur hautpflege
WO2014097258A3 (en) Aqueous cosmetic composition comprising alkylcellulose
WO2012081132A3 (en) Cosmetic composition in the form of an emulsion comprising small amount of emulsifier
JP2015512428A5 (de)
JP6639816B2 (ja) 化粧料
JP6554394B2 (ja) 化粧料
WO2012084605A3 (en) Leave-on composition comprising a laponite and an essential oil
WO2017011209A3 (en) Wipe, method for producing a wipe, and method for cleaning or moisturizing a patient's skin

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080012812.8

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10712702

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2012500151

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 4153/KOLNP/2011

Country of ref document: IN

Ref document number: 2010712702

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 20117024532

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 13257100

Country of ref document: US